Author:
Lumley James A.,Fallon David,Whatling Ryan,Coupry Damien,Brown Andrew
Reference53 articles.
1. Phase II and phase III failures: 2013–2015;Harrison;Nat. Rev. Drug Discov.,2016
2. Safety pharmacology–a progressive approach;Redfern;Fundam. Clin. Pharmacol.,2002
3. Drug withdrawals and the lessons within;Smith;Curr. Opin. Drug Discov. Dev.,2006
4. Innovation in the pharmaceutical industry: New estimates of R&D costs;DiMasi;J. Health Econ.,2016
5. Pharmacogenetics of drugs withdrawn from the market;Zhang;Pharmacogenomics,2012